Carregant...

Chemopotentiation in vivo: no loss of sensitization with fractionation.

The response of KHT sarcomas to one, two, five or ten daily fractions of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU), with and without misonidazole (MISO), was evaluated using delay of tumour regrowth as the measure of response. When CCNU was given as 2 dose fractions separated by 24 h rathe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hill, S. A., Siemann, D. W.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 1984
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1976902/
https://ncbi.nlm.nih.gov/pubmed/6487517
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!